The Claim

Intermediate cerebrospinal fluid tau levels are associated with aging-associated cognitive decline, falling between levels observed in healthy controls and those with Alzheimer's disease, suggesting a biological gradient that may reflect disease progression.

Source: CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
37score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

People who are aging and having trouble with memory or thinking tend to have a medium amount of a protein called tau in their spinal fluid—more than healthy people but less than those with Alzheimer’s. This might mean their brain changes are slowly getting worse.

See the scientific wording

Aging-associated cognitive decline is associated with intermediate cerebrospinal fluid tau levels between those of healthy controls and Alzheimer's disease patients, indicating a biological gradient that may reflect disease progression.

What the research says

1 study
  1. Study: CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease

    Scientists found that people with mild memory problems as they age have tau protein levels in their spinal fluid that are higher than healthy older adults but lower than those with Alzheimer’s — like a middle step on a ladder toward dementia.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.